LXRX - Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01 revenue of $0.01M February, 28 2022 06:05 AM Lexicon Pharmaceuticals Inc. Lexicon Pharmaceuticals press release (NASDAQ:LXRX): Q4 GAAP EPS of -$0.17 beats by $0.01. Revenue of $0.01M (-95.0% Y/Y). For further details see: Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01, revenue of $0.01M